Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 4/20 | 0.36 |
| ▸ | ACHE | P22303 | 3/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | STAT3 | P40763 | 1/20 | 0.31 |
| ▸ | S100A4 | P26447 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.30 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8903529 | 0.83 | PARP1 (0.35) | PARP1ACHEKEAP1NFE2L2STAT3 | |
| SCHEMBL8903467 | 0.75 | ACHE (0.57) | PARP1ACHEKEAP1NFE2L2STAT3 | |
| SCHEMBL2480306 | 0.73 | ACHE (0.41) | ACHESTAT3S100A4CSNK2A2CSNK2A1 | |
| SCHEMBL8734160 | 0.69 | ACHE (0.38) | ACHESTAT3S100A4CSNK2A2CSNK2A1 | |
| SCHEMBL6812230 | 0.68 | PARP1 (0.40) | PARP1KEAP1NFE2L2 | |
| SCHEMBL8903475 | 0.68 | ACHE (0.40) | ACHES100A4 | |
| SCHEMBL6808475 | 0.66 | BRD4 (0.45) | PARP1KEAP1NFE2L2 | |
| SCHEMBL181579 | 0.63 | ACHE (0.48) | ACHES100A4NOTUMCSNK2A2CSNK2A1 | |
| SCHEMBL9367273 | 0.63 | ACHE (0.48) | ACHES100A4NOTUMCSNK2A2CSNK2A1 | |
| SCHEMBL9372008 | 0.63 | ACHE (0.48) | ACHES100A4NOTUMCSNK2A2CSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5639911-A | Hydrazones | CIBA-GEIGY CORPORATION (US) | 1997-06-17 | — | — | US | disclosed |
| US-5461076-A | Inhibitors of S-adenosylmethionine decarboxylase; antitumor agents | NOVARTIS CORPORATION | 1995-10-24 | — | — | US | disclosed |
| EP-0456133-B1 | Hydrazones | CIBA GEIGY AG (CH) | 1995-03-15 | — | — | EP | disclosed |
| US-5395855-A | Antitumor agents | CIBA-GEIGY CORPORATION (US) | 1995-03-07 | — | — | US | disclosed |
| EP-0538193-A2 | Condensed cycloaliphatir-amidino-hydrazon salts as S-adenosylmethionin decarboxylase inhibitors | CIBA-GEIGY AG (CH) | 1993-04-21 | — | — | EP | disclosed |
| EP-0456133-A1 | Hydrazones | CIBA-GEIGY AG (CH) | 1991-11-13 | — | — | EP | disclosed |